drug

(atoltivimab + maftivimab + odesivimab)

Marketedupdated 3mo ago

by $REGN REGENERON PHARMACEUTICALS, INC.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying (atoltivimab + maftivimab + odesivimab)

phase2Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteersnot yet recruitingn=132

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

(atoltivimab + maftivimab + odesivimab)

Marketedupdated 3mo ago

by $REGN REGENERON PHARMACEUTICALS, INC.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying (atoltivimab + maftivimab + odesivimab)

phase2Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteersnot yet recruitingn=132

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 39m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

(atoltivimab + maftivimab + odesivimab)

all catalysts(0)

Trials studying (atoltivimab + maftivimab + odesivimab)

News(0)

Report a data issue

comments(0)

(atoltivimab + maftivimab + odesivimab)

all catalysts(0)

Trials studying (atoltivimab + maftivimab + odesivimab)

News(0)

Report a data issue

comments(0)